drug

Raloxifene Hydrochloride

Raloxifene hydrochloride
MeSH D020849
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by The Alfred
4 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

4
Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women
NCT03418831Phase 4Completed
Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia
NCT02354001Phase 4Completed
Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?
NCT01481883Phase 4Completed
Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia
NCT00361543Phase 4Completed

KOLs & investigators

2
Jayashri Kulkarni, MBBS, MPM, FRANZCP, PHDKOL score 5
LV QINYU

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
The Alfred
company
trial
Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women
PHASE4
trial
Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia
PHASE4
trial
Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?
PHASE4
trial
Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia
PHASE4
trial
indication
Schizophrenia
indication
Schizophreniform Disorder
indication
Mental Disorders
indication
Schizophrenia
indication
KOL
Jayashri Kulkarni, MBBS, MPM, FRANZCP, PHD
KOL score 5
person
LV QINYU
KOL score —
person